ENDO 2022

June 11-14, 2022

ENDO is the seminal meeting in hormone health and science, welcoming leading experts, researchers, and the most respected clinicians in the field to share the latest developments in endocrine research and patient care. In 2022, ENDO registrants have the option to attend the meeting in person in Atlanta, GA or virtually.

Crinetics will be making several oral and poster presentations at ENDO. Details of those presentations are as follows:

  1. (OR12) Inhibition of Basal and ACTH-Stimulated Cortisol Secretion in Humans Using an Oral, Nonpeptide ACTH Antagonist (CRN04894)
    Sunday, June 12, 2022 11:15 a.m. – 11:30 a.m. ET
    Oral Session; A404-A405
  2. (PSUN304) CRN04777, an Oral, Nonpeptide SST5-selective Somatostatin Agonist Dose Dependently Suppresses Basal and Stimulated Insulin Secretion
    Sunday, June 12, 2022 12:30 p.m. – 2:30 p.m. ET
    Poster+ Session; Hall A1
  3. (LBSAT142) Discovery and Characterization of a Potent and Orally Bioavailable Parathyroid Hormone Receptor Type-1 (PTHR1) Antagonist for the Treatment of Hypercalcemia
    Saturday, June 11, 2022 1:00 p.m. – 3:00 p.m. ET
    Poster+ Session; HallA1